Order Article Reprints

Tabouret E, Wang H, Amin N, Jung J, Appay R, Cui J, Song Q, Cardone A, Park DM, Gilbert MR, et al. Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. Cancers 2020, 12, 1935. Cancers. 2025; 17(19):3094. https://doi.org/10.3390/cancers17193094

Tabouret, Emeline, Herui Wang, Niranjana Amin, Jinkyu Jung, Romain Appay, Jing Cui, Qi Song, Antonio Cardone, Deric M. Park, Mark R. Gilbert, and et al. 2025. "Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. Cancers 2020, 12, 1935" Cancers 17, no. 19: 3094. https://doi.org/10.3390/cancers17193094

Tabouret, E., Wang, H., Amin, N., Jung, J., Appay, R., Cui, J., Song, Q., Cardone, A., Park, D. M., Gilbert, M. R., Pant, H., & Zhuang, Z. (2025). Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. Cancers 2020, 12, 1935. Cancers, 17(19), 3094. https://doi.org/10.3390/cancers17193094